FDA Issues Nationwide Recall of Blood Pressure Medication Linked to Cancer Risk

The U.S. Food and Drug Administration (FDA) has announced the recall of over 580,000 bottles of the blood pressure medication prazosin hydrochloride due to potential contamination with a chemical linked to cancer. This voluntary recall was initiated by Teva Pharmaceuticals USA and Amerisource Health Services earlier in March 2024, affecting various strengths of prazosin capsules distributed nationwide.

Healthcare professionals prescribe prazosin to relax blood vessels and lower blood pressure. It is also used to manage nightmares and other sleep disturbances associated with post-traumatic stress disorder. The FDA’s enforcement orders, available online, have classified the affected lots of the drug as Class II risk. This classification indicates that the recalled medications may contain N-nitrosamine impurities, which are recognized as potentially cancer-causing.

N-nitrosamines can form during the manufacturing or storage processes of certain drugs. The FDA’s ongoing efforts to ensure drug safety have led to increased scrutiny of medications containing these impurities. The agency advises healthcare providers to review their inventories for the affected lots and to communicate with patients regarding the recall.

As a precaution, patients taking these medications should consult their healthcare providers for alternative treatments and further guidance. The FDA emphasizes its commitment to patient safety and the importance of addressing any potential health risks associated with contaminated medications.

This recall highlights the ongoing challenges faced by pharmaceutical manufacturers and regulators in maintaining drug safety standards. As investigations continue, both Teva Pharmaceuticals and Amerisource Health Services are working closely with the FDA to manage the recall process and mitigate any potential health risks to patients.

In light of this development, consumers are encouraged to stay informed and consult official FDA resources for updates regarding the recall and any necessary actions they should take.